A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease
Clinical trial NCT04884815 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04884815
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-27
- Primary completion
- 2029-03-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.